Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 6,150.00
-440.00 (-6.68%)
Aug 7, 2026, 3:30 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 170.22 billion as of August 7, 2026. Its market cap has increased by 60.16% in one year.
Market Cap
170.22B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
101.93
Stock Price
6,150.00
ChartMarket Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 170.22B, an increase of 491.55%. That is a compound annual growth rate of 5.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 170.22B | -27.82% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whan In Pharm | 192.23B |
| Chong Kun Dang Holdings | 190.42B |
| REYON Pharmaceutical | 183.96B |
| JW Lifescience | 178.23B |
| BNC KOREA | 177.83B |
| Daewon Pharmaceutical | 174.90B |
| Daihan Pharmaceutical | 158.76B |
| Hana Pharm | 157.82B |